Recall Register

Food, drugs, devices › Ambu Inc.

Device recall: Ambu¿ VivaSight 2 DLT Endobronchial tube, 35 FR (Catalog Number 412351000), 37 Fr (Catalog Number 412371000), 39 Fr (Cat

FDA enforcement event 95454 · Class II · initiated 16 Sep 2024 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordColumbia, MD

Ambu Inc. (Columbia, MD) initiated this device recall on 16 Sep 2024; FDA lists 1 product record under event 95454, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 87% of the 970 device enforcement events initiated in 2024 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Ambu Inc. has 7 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Ambu Inc., Columbia, MD.

Reason for recall

"Ambu has received complaints on Ambu¿ VivaSight 2 DLTs regarding hyper angulation of the distal end. The hyper angulation can lead to an increased risk of complications during intubation and potential airway injury."

Distribution

"US Nationwide. Canada."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0261-2025Ambu¿ VivaSight 2 DLT Endobronchial tube, 35 FR (Catalog Number 412351000), 37 Fr (Catalog Number 412371000), 39 Fr (Catalog Number 412391000), 41 Fr (Catalog Number 412411000)1824Class IIOngoing6 Nov 2024

Context

87%of 2024 device events are Class II970 events that year
1product record in this eventfirm median: 1
7events on this register for the firm

Other enforcement events for Ambu Inc.

InitiatedProduct (first record)TypeClassRecords
9 Jul 2025Ambu SPUR II Labeled as the following: 1 SPUR II Adult Resuscitator, Adult, Catalog Number: 523211000 2 SPUR II Adult ReDeviceClass I1
7 Apr 2025Ambu aScope" 5 Broncho HD 5.6/2.8 Sampler Set. Model Number: 622002000USDeviceClass II1
5 Dec 2023Ambu aView 2 A Monitor, Catalog numbers 405011000 and 405011000US2DeviceClass II1
21 Jul 2023Ambu aView 2 A Monitor-The Ambu aView 2 Advance is intended to display live imaging data from compatible Ambu visualizatDeviceClass II1
3 Jun 2022Ambu VivaSight 2 DLT; endobronchial tube system used for verifying tube placement and repositioning. Catalog numbers 412DeviceClass II1
10 Feb 2016Ambu, Aura Gain - Single Use Laryngeal Mask- Sterile for use as an alternative to a face mask for achieving and maintainDeviceClass II1

All 7 events for Ambu Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Ambu has received complaints on Ambu¿ VivaSight 2 DLTs regarding hyper angulation of the distal end. The hyper angulation can lead to an increased risk of complications during intubation and potential airway injury."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide. Canada."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.